resTORbio, Inc. License Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 to Amended and Restated License Agreement, dated as of January 13, 2016, by and between Technion Research and Development Foundation Ltd., Applied Immune...
License Agreements
resTORbio, Inc.
Pharmaceuticals
2020
Amendment No. 1 to Amended and Restated License Agreement, dated as of June 30, 2015, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself...
License Agreements
resTORbio, Inc.
Pharmaceuticals
2020
Amended and Restated License Agreement, dated as of May 21, 2014, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself and the...
License Agreements
resTORbio, Inc.
Pharmaceuticals
2020
Amendment No. 2 to Amended and Restated License Agreement, dated as of January 13, 2016, by and between Technion Research and Development Foundation Ltd., Applied Immune...
License Agreements
resTORbio, Inc.
Pharmaceuticals
2020
Amendment No. 1 to Amended and Restated License Agreement, dated as of June 30, 2015, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself...
License Agreements
resTORbio, Inc.
Pharmaceuticals
2020
Amended and Restated License Agreement, dated as of May 21, 2014, by and between Technion Research and Development Foundation Ltd., acting on behalf of itself and the...
License Agreements
resTORbio, Inc.
Pharmaceuticals
2020
Amendment No. 2 to License Agreement, dated August 20, 2019, by and between the Registrant and Novartis International Pharmaceutical Ltd
License Agreements
resTORbio, Inc.
Pharmaceuticals
2019
License Agreement, dated as of March 23, 2017, by and between the Registrant and Novartis International Pharmaceutical Ltd
License Agreements
resTORbio, Inc.
Pharmaceuticals
MA
2018
First Amendment to the License Agreement, dated as of October 3, 2017, by and among the Registrant and Novartis International Pharmaceutical Ltd
License Agreements
resTORbio, Inc.
Pharmaceuticals
2017
License Agreement, dated as of March 23, 2017, by and between the Registrant and Novartis International Pharmaceutical Ltd
License Agreements
resTORbio, Inc.
Pharmaceuticals
MA
2017